Table 2. Comparison of the production by South American countries with the number of annual cases of leishmaniasis and other indicators of scientific/technological development.
| N° | Country | Papers published | CL cases/yeara | VL cases/yeara | RDE b (million dollars) | RDE/GDP %b |
|---|---|---|---|---|---|---|
| 1 | Brazil | 3552 | 26008 | 3481 | 20,237.6 | 1.07 |
| 2 | Venezuela | 285 | 2480 | 40 | ND | ND |
| 3 | Colombia | 256 | 17420 | 60 | 600.6 | 0.16 |
| 4 | Argentina | 218 | 261 | 8 | 2,658.7 | 0.51 |
| 5 | Peru | 124 | 6405 | - | 238.1 | 0.15 |
| 6 | Bolivia | 44 | 2647 | - | ND | 0.26 |
| 7 | Ecuador | 35 | 1724 | - | 145.9 | 0.15 |
| 8 | Paraguay | 19 | 431 | 48 | 20.1 | 0.20 |
CL. Cutaneous Leishmania, VL: Visceral Leishmania, RDE: Research and Development Expenditure, GDP: Gross domestic product.
a
Source: Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS one. 2012;7(5):e35671(Alvar et al. 2012).
b
UNESCO (2010) UNESCO Science Report. The Current Status of Science around the World.